Skip to main content

[18F]fluorocholine PET/CT in the assessment of bone metastases in prostate cancer

European Journal of Nuclear Medicine and Molecular Imaging volume 34, pages 1316–1317 (2007)Cite this article

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Cimitan M, Bortolus R, Morassut S, Canzonieri V, Garbeglio A, Baresic T, et al. [18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients. Eur J Nucl Med Mol Imaging 2006;33:1387–98.

    Article  PubMed  Google Scholar 

  2. Langsteger W, Heinisch M, Fogelman I. The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast. Semin Nucl Med 2006;36:73–92.

    Article  PubMed  Google Scholar 

  3. Langsteger W, Beheshti M, Poecher S, Loidl W, Haim S, Stoiber F, et al. Fluor choline (FCH) positron emission tomography/computed tomography in preoperative staging and follow up of prostate cancer patients. Mol Imag Biol 2006;8(2):69.

    Google Scholar 

  4. Beheshti M, Haim S, Nader M, Poecher S, Jordanova N, Stoiber F, et al. Assessment of bone metastases in patients with prostate cancer by dual-phase F-18 fluor choline PET/CT. Eur J Nucl Med Mol Imaging 2006;33 Suppl 2:208.

    Google Scholar 

  5. Langsteger W, Beheshti M, Nader M, Stoiber F, Loidl W, Fitz F, et al. Evaluation of lymph node and bone metastases with fluor choline (FCH) PET-CT in the follow up of prostate cancer patients. Eur J Nucl Med Mol Imaging 2006;33 Suppl 2:209.

    Google Scholar 

Download references

Author information

Affiliations

  1. Department of Nuclear Medicine and Endocrinology, St. Vincent’s Hospital; PET-CT Center LINZ, Seilerstaette 4, 4010, Linz, Austria

    Mohsen Beheshti, Reza Vali & Werner Langsteger

Authors
  1. Mohsen Beheshti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Reza Vali
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Werner Langsteger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mohsen Beheshti.

Additional information

An authors’ reply to this letter is available at http://dx.doi.org/10.1007/s00259-007-0402-9.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Beheshti, M., Vali, R. & Langsteger, W. [18F]fluorocholine PET/CT in the assessment of bone metastases in prostate cancer. Eur J Nucl Med Mol Imaging 34, 1316–1317 (2007). https://doi.org/10.1007/s00259-007-0401-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-007-0401-x

Keywords

  • Hormone Therapy
  • Bone Metastasis
  • Gleason Score
  • Bone Marrow Involvement
  • Recurrent Prostate Cancer